optimal ngs platforms, how to interpret - grace targeted therapies in lung cancer patient forum 2021
Published 2 years ago • 98 plays • Length 21:33Download video MP4
Download video MP3
Similar videos
-
7:27
intro and cancer 101 - grace targeted therapies in lung cancer patient forum 2021
-
18:40
liquid biopsies: future applications - grace targeted therapies in lung cancer patient forum 2021
-
4:42
grace targeted therapies in lung cancer 2021 - anxiety burden: wait for results, beginning treatment
-
17:58
grace targeted therapies lung cancer 2021 - kras directed therapies: a new horizon
-
21:58
grace targeted therapies lung cancer 2021 - alk therapies-which one comes first, how do we sequence?
-
5:30:11
full event mainstage 2023 targeted therapies in lung cancer patient forum on-demand
-
4:40
grace targeted therapies in lung cancer 2021 - cost & care for liquid & tissue biopsy monitoring
-
17:53
grace targeted therapies lung cancer 2021 - genotype directed therapy: role in earlier stage disease
-
6:32
grace targeted therapies in lung cancer 2021 - diagnosis and testing: what tests are relevant
-
4:06
grace targeted therapies in lung cancer 2021 - repeat biopsy before next line targeted therapy?
-
2:05
grace targeted therapies lung cancer 2021 - bypass mechanisms (pik3, mek, erk, etc)
-
2:43
grace targeted therapies in lung cancer 2021 - opinions on various costs and treatment options
-
2:02
grace targeted therapies lung cancer 2021 - second line ros1 medication off-label
-
14:33
grace targeted therapies lung cancer 2021 - targeted therapies in oligo-metastatic disease
-
6:18
grace targeted therapies lung cancer 2021 - will there ever be opportunity to use tki io together?
-
2:34
grace targeted therapies lung cancer 2021 - recommended firstline treatment for kras k12c?
-
4:02
grace targeted therapies in lung cancer 2021 - future, telemedicine & interstate treatment
-
4:31
grace targeted therapies lung cancer 2021 -recommended 2nd line & timing, stage 3 ros-1 lung cancer?
-
8:46
grace targeted therapies in lung cancer 2021 - liquid and tissue biopsies in acquired resistance